Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT06872060
Eligibility Criteria:
Inclusion Criteria:
* Normal health confirmed through; Interview and Medical examination
* Normal values with respect to blood concentrations of fasting plasma glucose, fasting plasma total cholesterol, fasting triglycerides, HDL, LDL, creatinine, liver function tests, and electrolytes
* Informed consent
Exclusion Criteria:
* Immunosuppressive treatment in the previous 12 months
* Alcohol abuse
* Medical treatment with oral glucocorticoids, dipeptidyl peptidase-4 (DPP-4) inhibitors, or GLP-1 receptor agonists, which, in the opinion of the principal investigator, may interfere with glucose metabolism
* Use of lithium
* Medical treatment that affects insulin secretion or the renin-angiotensin-aldosterone system
* Liver disease (ALT \> 2x normal value)
* Renal impairment (serum creatinine \> 130 µM and/or albuminuria)
* Individuals with severe claustrophobia
* Individuals with MR-incompatible foreign bodies
* Individuals with hypertension
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
20 Years
Maximum Age:
60 Years
Study:
NCT06872060
Study Brief:
Protocol Section:
NCT06872060